ATE390921T1 - Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung - Google Patents
Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendungInfo
- Publication number
- ATE390921T1 ATE390921T1 AT01951327T AT01951327T ATE390921T1 AT E390921 T1 ATE390921 T1 AT E390921T1 AT 01951327 T AT01951327 T AT 01951327T AT 01951327 T AT01951327 T AT 01951327T AT E390921 T1 ATE390921 T1 AT E390921T1
- Authority
- AT
- Austria
- Prior art keywords
- platinum
- combination
- containing anticancer
- anticancer agents
- demethylcantharidine
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
- 229960004562 carboplatin Drugs 0.000 abstract 2
- 190000008236 carboplatin Chemical compound 0.000 abstract 2
- 229960004316 cisplatin Drugs 0.000 abstract 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 229960001756 oxaliplatin Drugs 0.000 abstract 2
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2001/000885 WO2002096413A1 (en) | 2001-05-31 | 2001-05-31 | Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE390921T1 true ATE390921T1 (de) | 2008-04-15 |
Family
ID=4574808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01951327T ATE390921T1 (de) | 2001-05-31 | 2001-05-31 | Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040152766A1 (de) |
| EP (1) | EP1390027B1 (de) |
| JP (1) | JP2004532260A (de) |
| CN (1) | CN1237065C (de) |
| AT (1) | ATE390921T1 (de) |
| DE (1) | DE60133491D1 (de) |
| WO (1) | WO2002096413A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235700B2 (en) * | 2003-03-28 | 2007-06-26 | Meiji Dairies Corporation | Process for producing cyclohexenone long-chain alcohols |
| CN1680384A (zh) * | 2004-04-08 | 2005-10-12 | 香港中文大学 | 去甲基斑蟊素铂配合物及其用途 |
| MX385473B (es) * | 2014-12-17 | 2025-03-18 | Verrica Pharmaceuticals Inc | Sintesis comercialmente viable de cantaridina y derivados bioactivos de cantaridina. |
| CA2988989A1 (en) * | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| IL314274A (en) | 2017-06-06 | 2024-09-01 | Verrica Pharmaceuticals Inc | Treatment of skin disorders |
| CN116474253A (zh) | 2017-06-15 | 2023-07-25 | 维里卡制药有限公司 | 用于治疗身体表面病症的装置和方法 |
| USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
| BR112020006703A2 (pt) | 2017-10-04 | 2020-10-06 | Verrica Pharmaceuticals, Inc. | síntese de cantaridina |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068002C (zh) * | 1997-04-30 | 2001-07-04 | 中国科学院大连化学物理研究所 | 铂抗癌药物及合成 |
| AUPP466598A0 (en) * | 1998-07-14 | 1998-08-06 | University Of Newcastle Research Associates Limited, The | Product and process |
-
2001
- 2001-05-31 EP EP01951327A patent/EP1390027B1/de not_active Expired - Lifetime
- 2001-05-31 CN CNB018231403A patent/CN1237065C/zh not_active Expired - Fee Related
- 2001-05-31 JP JP2002592923A patent/JP2004532260A/ja active Pending
- 2001-05-31 DE DE60133491T patent/DE60133491D1/de not_active Expired - Lifetime
- 2001-05-31 US US10/479,441 patent/US20040152766A1/en not_active Abandoned
- 2001-05-31 WO PCT/CN2001/000885 patent/WO2002096413A1/en not_active Ceased
- 2001-05-31 AT AT01951327T patent/ATE390921T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1064955A1 (en) | 2005-02-08 |
| WO2002096413A1 (en) | 2002-12-05 |
| JP2004532260A (ja) | 2004-10-21 |
| EP1390027A4 (de) | 2004-06-30 |
| EP1390027B1 (de) | 2008-04-02 |
| US20040152766A1 (en) | 2004-08-05 |
| DE60133491D1 (de) | 2008-05-15 |
| EP1390027A1 (de) | 2004-02-25 |
| CN1499966A (zh) | 2004-05-26 |
| CN1237065C (zh) | 2006-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200635923A (en) | Tricyclic heterocycles, their manufacture and use as pharmaceutical agents | |
| ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
| ATE538103T1 (de) | Chinazolinonverbindungen als antikrebsmittel | |
| MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
| PL1742644T3 (pl) | Kompozycja terapeutyczna zawierająca co najmniej jedną pochodną pirolobenzodiazepiny i fludarabiny | |
| DE60001974D1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
| WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
| TR200100054T2 (tr) | Paroksetin metansülfonat | |
| TW200624431A (en) | Phthalazinone derivatives, their manufacture and use as pharmaceutical agents | |
| WO2002102306A8 (en) | Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy | |
| ATE291424T1 (de) | Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung | |
| PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
| DE60209721D1 (de) | Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| ATE499372T1 (de) | Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel | |
| DE60133491D1 (de) | Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
| ATE390124T1 (de) | Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin | |
| HUP0203153A2 (hu) | Kombinációs kemoterápia | |
| EP1558282A4 (de) | Zusammensetzungen gegen krebs und infektionskrankheiten und anwendungsverfahren dafür | |
| DE602005011031D1 (en) | Phosphoindole als hiv-inhibitoren | |
| IL147890A0 (en) | Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |